alan semaglutide Oh great AG Alan Wilson leads coalition

The Medicare GLP-1 Bridge program represents a historic shift in how the federal government views obesity treatment for beneficiaries, but its not clear what will happen beyond 18 months

Gill told Action News that demand for the Wegovy pill is already growing after its release was announced Monday

Much of this growth is due to the effectiveness of GLP-1RA medications as weight loss drugs

Learn more about IPL photofacial Medford patients: See our dedicated IPL photofacial for Medford patients page for Medford-specific guidance

Novo Nordisk, the manufacturer of Ozempic and Wegovy, contends vision loss is not considered a potential adverse reaction for drugs containing semaglutide